Valuation: DBV Technologies

Market Cap 516M 579M 478M 432M 815M 54.65B 824M 5.73B 2.25B 28.73B 2.17B 2.13B 91.54B P/E 2026 *
-4.26x
P/E 2027 * -12.1x
Enterprise Value 449M 504M 416M 376M 709M 47.55B 717M 4.98B 1.96B 24.99B 1.89B 1.85B 79.64B EV / Sales 2026 *
125x
EV / Sales 2027 * 6.38x
Free-Float
99.85%
Yield 2026 *
-
Yield 2027 * -
1 day+1.93%
1 week+9.20%
Current month-15.91%
1 month-18.20%
3 months-29.51%
6 months-49.15%
Current year-48.40%
1 week 1.53
Extreme 1.534
1.76
1 month 1.53
Extreme 1.534
2.22
Current year 1.53
Extreme 1.534
4.4
1 year 1.53
Extreme 1.534
4.5
3 years 0.51
Extreme 0.506
4.5
5 years 0.51
Extreme 0.506
9.48
10 years 0.51
Extreme 0.506
86.64
Manager TitleAgeSince
Chief Executive Officer 66 28/11/2018
Director of Finance/CFO 56 05/11/2023
Chief Operating Officer - 30/11/2023
Director TitleAgeSince
Director/Board Member 51 20/10/2015
Director/Board Member 63 20/06/2016
Director/Board Member 60 14/06/2017
Date Insider Type Main position Quantity % Market Cap. Importance
29/07/26 Sell

Chief Technology Officer

-464 0.0002%
29/01/26 Sell

Chief Technology Officer

534 0.0003%
12/01/26
Baker Bros. Advisors LP
ExerciceCompany 54,609,792 27.1991%
Change 5-day change 1-year change 3-year change Capi.($)
+1.93%+9.20%-37.04%-17.58% 569M
-1.01%+5.13%+58.93%+117.36% 1,144B
-0.61%+1.52%+34.34%+68.48% 625B
-1.48%+0.47%+23.08%+94.76% 511B
+0.54%+5.69%+39.60%+64.02% 377B
+1.07%+1.70%+71.06%+45.98% 366B
+0.30%+3.44%+21.35%+49.62% 291B
-0.03%+2.55%+1.12%+20.94% 262B
-0.14%+2.87%+45.56%+57.22% 237B
-1.88%+0.02%+23.77%+97.39% 194B
Average +0.16%+4.34%+28.18%+59.82% 400.85B
Weighted average by Cap. +0.33%+4.17%+40.80%+79.55%

Financials

2026 *2027 *
Net sales 3.6M 4.04M 3.33M 3.02M 5.68M 381M 5.75M 39.96M 15.68M 200M 15.15M 14.84M 638M 62.28M 69.89M 57.66M 52.18M 98.31M 6.6B 99.47M 691M 271M 3.47B 262M 257M 11.05B
Net income -174M -196M -161M -146M -275M -18.45B -278M -1.93B -759M -9.7B -733M -718M -30.9B -126M -142M -117M -106M -199M -13.36B -201M -1.4B -549M -7.02B -531M -520M -22.37B
Net Debt -67.1M -75.3M -62.12M -56.22M -106M -7.11B -107M -745M -292M -3.73B -282M -277M -11.9B -119M -134M -110M -99.75M -188M -12.61B -190M -1.32B -519M -6.63B -501M -491M -21.12B
Projected Income Statement - Annual - DBV Technologies
Logo DBV Technologies
DBV Technologies specializes in developing solutions for diagnosing and treating food allergies (primarily to peanuts and cow's milk) using a patch (Viaskin®) that administers active ingredients into the top layers of the skin.
Employees
170
Date Price Change Volume
21/10/26 €1.744 +1.93% 1,274,074
20/10/26 €1.711 +7.34% 1,321,002
19/10/26 €1.594 +1.66% 1,165,181
16/10/26 €1.568 -3.39% 1,343,700
15/10/26 €1.623 +1.63% 1,027,645
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
MarketScreener Ratings - DBV Technologies
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
4
Last Close Price
1.744EUR
Average target price
3.637EUR
Spread / Average Target
+108.52%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - DBV Technologies